Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 6,206 | 7,574↑22.1% | 8,931↑17.9% | 9,869↑10.5% | 11,020↑11.7% |
| Cost Of Revenue | 736 | 904↑22.8% | 1,080↑19.5% | 1,262↑16.8% | 1,531↑21.3% |
| Gross Profit | 5,469 | 6,670↑22.0% | 7,850↑17.7% | 8,607↑9.6% | 9,490↑10.3% |
| Operating Expenses | 2,613 | 3,891↑48.9% | 3,543↓8.9% | 4,775↑34.8% | 9,723↑103.6% |
| Operating Income | 2,856 | 2,782↓2.6% | 4,307↑54.8% | 3,832↓11.0% | -233↓106.1% |
| Interest Expense | 58 | 62↑5.8% | 55↓10.9% | 44↓19.5% | 31↓30.6% |
| Income Before Tax | 3,117 | 2,730↓12.4% | 4,232↑55.0% | 4,380↑3.5% | 249↓94.3% |
| Income Tax Expense | 405 | 388↓4.2% | 910↑134.5% | 760↓16.5% | 784↑3.1% |
| Net Income | 2,712 | 2,342↓13.6% | 3,322↑41.8% | 3,620↑9.0% | -536↓114.8% |
| EBITDA | 3,284 | 2,918↓11.2% | 4,436↑52.0% | 4,605↑3.8% | 486↓89.4% |
| EPS | 10.44 | 9.09↓12.9% | 12.97↑42.7% | 14.05↑8.3% | -2.08↓114.8% |
| EPS Diluted | 10.29 | 9.01↓12.4% | 12.82↑42.3% | 13.89↑8.3% | -2.08↓115.0% |